These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37377552)

  • 21. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [MR vaccine].
    Nakayama T
    Nihon Rinsho; 2011 Sep; 69(9):1573-8. PubMed ID: 21922755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques.
    Joyce JC; Carroll TD; Collins ML; Chen MH; Fritts L; Dutra JC; Rourke TL; Goodson JL; McChesney MB; Prausnitz MR; Rota PA
    J Infect Dis; 2018 Jun; 218(1):124-132. PubMed ID: 29701813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measles and Rubella Global Strategic Plan 2012-2020 midterm review.
    Orenstein WA; Hinman A; Nkowane B; Olive JM; Reingold A
    Vaccine; 2018 Jan; 36 Suppl 1():A1-A34. PubMed ID: 29307367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A measles and rubella (MR) catch-up vaccination campaign in an Egyptian University: vaccine uptake and knowledge and attitudes of students.
    Abd Elaziz KM; Sabbour SM; Dewedar SA
    Vaccine; 2010 Nov; 28(47):7563-8. PubMed ID: 20797454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation and evaluation of a measles/rubella vaccination campaign in a campus university in the UK following an outbreak of rubella.
    Stevenson J; Murdoch G; Riley A; Duncan B; McWhirter M; Christie P
    Epidemiol Infect; 1998 Aug; 121(1):157-64. PubMed ID: 9747767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The strategy for prevention of measles and rubella prevalence with measles-rubella (MR) vaccine in Japan.
    Ihara T
    Vaccine; 2009 May; 27(24):3234-6. PubMed ID: 19366578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of measles-rubella vaccine administered under India's Universal Immunization Programme in the context of measles-rubella elimination goal: A longitudinal study.
    Verma SK; Shah D; Singh A; Singh PK; Das S; Gupta P
    Indian J Med Res; 2023 Apr; 157(4):250-258. PubMed ID: 37102515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic Review of Health Economic Analyses of Measles and Rubella Immunization Interventions.
    Thompson KM; Odahowski CL
    Risk Anal; 2016 Jul; 36(7):1297-314. PubMed ID: 25545778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The elimination of measles and rubella in Italy].
    Adamo G; Sturabotti G; De Soccio P; Prencipe GP; Sciarra I; Baccolini V; Massimi A; Marzuillo C; Iannazzo S; Villari P
    Ig Sanita Pubbl; 2017; 73(5):429-442. PubMed ID: 29433130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and immunogenicity of inactivated poliovirus vaccine when given with measles-rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia.
    Clarke E; Saidu Y; Adetifa JU; Adigweme I; Hydara MB; Bashorun AO; Moneke-Anyanwoke N; Umesi A; Roberts E; Cham PM; Okoye ME; Brown KE; Niedrig M; Chowdhury PR; Clemens R; Bandyopadhyay AS; Mueller J; Jeffries DJ; Kampmann B
    Lancet Glob Health; 2016 Aug; 4(8):e534-47. PubMed ID: 27364568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.
    Tohme RA; François J; Wannemuehler K; Magloire R; Danovaro-Holliday MC; Flannery B; Cavallaro KF; Fitter DL; Purcell N; Dismer A; Tappero JW; Vertefeuille JF; Hyde TB
    Trop Med Int Health; 2014 Sep; 19(9):1105-15. PubMed ID: 25041586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress Toward Measles and Rubella Elimination - India, 2005-2021.
    Murugan R; VanderEnde K; Dhawan V; Haldar P; Chatterjee S; Sharma D; Dzeyie KA; Pattabhiramaiah SB; Khanal S; Sangal L; Bahl S; Tanwar SSS; Morales M; Kassem AM
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(50):1569-1575. PubMed ID: 36520657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination.
    Rainey JJ; Danovaro-Holliday MC; Magloire R; Kananda G; Lee CE; Chamouillet H; Lacapere F; Mung K; Luman ET
    J Infect Dis; 2011 Sep; 204 Suppl 2():S616-21. PubMed ID: 21954256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in the elimination of measles and congenital rubella in Central Italy.
    Bechini A; Levi M; Boccalini S; Tiscione E; Panatto D; Amicizia D; Bonanni P
    Hum Vaccin Immunother; 2013 Mar; 9(3):649-56. PubMed ID: 23292174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Communication lessons learned from the 2017 measles-rubella campaign in India: perspectives from vaccine decision-makers.
    Limaye RJ; Gupta M; Bansal A; Chandler MK; Santosham M; Erchick DJ
    Health Promot Int; 2022 Oct; 37(5):. PubMed ID: 36287519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital Rubella Syndrome Surveillance After Measles Rubella Vaccination Introduction in Yogyakarta, Indonesia.
    Herini ES; Triono A; Iskandar K; Prasetyo A; Nugrahanto AP; Gunadi
    Pediatr Infect Dis J; 2021 Dec; 40(12):1144-1150. PubMed ID: 34609101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of the World's largest measles-rubella mass vaccination campaign in Bangladesh: a process evaluation.
    Sarma H; Budden A; Luies SK; Lim SS; Shamsuzzaman M; Sultana T; Rajaratnam JK; Craw L; Banwell C; Ali MW; Uddin MJ
    BMC Public Health; 2019 Jul; 19(1):925. PubMed ID: 31291922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Activities to catch up and Vaccinate the Susceptible Population in Valencian Community, Spain].
    Martín-Ivorra R; Alguacil-Ramos AM; Lluch-Rodrigo JA; Pastor-Villalba E; Portero-Alonso A
    Rev Esp Salud Publica; 2015; 89(4):419-26. PubMed ID: 26580797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.